Detalles de la búsqueda
1.
Pathological and clinical outcomes following neoadjuvant dual HER2 therapy for early-stage breast cancer: An Australian institutional real-world experience.
Cancer Med;
13(12): e7325, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38899493
2.
Has the COVID-19 pandemic resulted in more advanced breast cancer? A hospital-based retrospective study.
ANZ J Surg;
2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38747551
3.
A practical guide for the use of apalutamide for non-metastatic castration-resistant prostate cancer in Australia.
Asia Pac J Clin Oncol;
2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38639402
4.
Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer.
Prostate;
84(8): 747-755, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38544345
5.
Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity.
J Natl Compr Canc Netw;
22(2): 108-116, 2024 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38364373
6.
Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells.
Clin Cancer Res;
30(2): 304-314, 2024 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37976042
7.
Outcomes of endoscopic ultrasound-guided gastro-enterostomy for gastric outlet obstruction in a two-centre Australian Cohort (with video).
Asia Pac J Clin Oncol;
20(1): 87-92, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37771144
8.
Sleep dysfunction associated with worse chemotherapy-induced peripheral neurotoxicity functional outcomes.
Support Care Cancer;
32(1): 46, 2023 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38117349
9.
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.
Lancet Oncol;
24(4): 323-334, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36990608
10.
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer.
Breast;
67: 94-101, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36702070
11.
Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA).
Int J Cancer;
152(2): 267-275, 2023 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36005450
12.
Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy.
Asia Pac J Clin Oncol;
19(1): 243-249, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35879821
13.
The Utility of the Oncotype DX Test for Breast Cancer Patients in an Australian Multidisciplinary Setting.
Breast J;
2022: 1199245, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35711899
14.
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer.
BMC Med;
20(1): 112, 2022 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35331214
15.
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP.
J Clin Oncol;
40(8): 837-846, 2022 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34928708
16.
Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate Cancer.
Cancers (Basel);
13(19)2021 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638448
17.
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase.
EBioMedicine;
72: 103625, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34656931
18.
Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy.
Eur Urol;
80(3): 275-279, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34030924
19.
The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].
PLoS One;
15(3): e0229900, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32142532
20.
Taxane-induced peripheral neuropathy: differences in patient report and objective assessment.
Support Care Cancer;
28(9): 4459-4466, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31925531